Results 71 to 80 of about 22,824 (81)

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

Genetics in Medicine, 2019
Atsumi Taguchi, Akifumi Onishi, Hitoshi Sugiyama   +2 more
exaly  

Fabry Disease Biomarkers: Analysis of Urinary Lyso‐Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry

Current Protocols in Human Genetics, 2016
Michel Boutin, Christiane Auray-Blais
exaly  

Enzymatic synthesis of Gb3 and iGb3 ceramides

Carbohydrate Research, 2010
Joel T Weadge, Jens Øllgaard Duus
exaly  

Synthesis of an Aminooxy Derivative of the Trisaccharide Globotriose Gb3

Journal of Carbohydrate Chemistry, 2014
Samir Ghosh, Peter Andreana
exaly  

Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression

BMB Reports, 2009
exaly  

One-step synthesis of carbon-13-labeled globotriaosylsphingosine (lyso-Gb3), an internal standard for biomarker analysis of Fabry disease

Molecular Genetics and Metabolism, 2018
Michael H Gelb
exaly  

Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 1995
Ewa Rajpert-De Meyts
exaly  

Immunohistologic techniques for detecting the glycolipid Gb3 in the mouse kidney and nervous system

Histochemistry and Cell Biology, 2008
Glynis L Kolling, Fumiko Obata
exaly  

The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: A systematic literature review

Molecular Genetics and Metabolism
Uma Ramaswami, Albina Nowak, Michael L West   +2 more
exaly  

Multi-Year Continuous PM2.5 Measurements with the Federal Equivalent Method SHARP 5030 and Comparisons to Filter-Based and TEOM Measurements in Ontario, Canada

Atmosphere, 2018
exaly